Parmax Pharma Limited share price
BSE: PARMAX
Key numbers
- Market cap
- ₹ 51.0 Cr
- Current price
- ₹ 136.40
- 52-week high / low
- ₹ 136 / 23
- Stock P/E
- -
- Book value
- ₹ -16.4
- Dividend yield
- 0.00%
- ROCE
- -77.6%
- ROE
- 102.2%
- Debt to equity
- -1.96
- Sales growth (3 yrs)
- -7.7%
- Profit growth (3 yrs)
- -
- 1-year return
- 314.3%
About Parmax Pharma Limited
Parmax Pharma Limited operates in the pharmaceutical business in India. It manufactures and sells bulk drugs, drug intermediates, and specialty chemicals. The company was incorporated in 1994 and is based in Rajkot, India.
Quarterly results
Consolidated figures in ₹ crores
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Sales | 2 | 3 | 4 | 3 | 8 |
| Operating profit | -0 | -2 | -0 | -2 | 1 |
| Net profit | -1 | -2 | -1 | -1 | 2 |
| EPS (₹) | -2.04 | -5.56 | -1.96 | -1.56 | 5.88 |
Peers in Drug Manufacturers - Specialty & Generic
Data for information only, not investment advice. Prices end of day.